PT  - JOURNAL ARTICLE
ED  - , 
TI  - SKP2 Is a Potential Cancer Drug Target
AID  - 10.1158/2159-8290.CD-RW2013-175
DP  - 2013 Oct 01
TA  - Cancer Discovery
PG  - OF30--OF30
VI  - 3
IP  - 10
4099  - http://cancerdiscovery.aacrjournals.org/content/3/10/OF30.short
4100  - http://cancerdiscovery.aacrjournals.org/content/3/10/OF30.full
SO  - CANCER DISCOVERY2013 Oct 01; 3
AB  - A selective inhibitor of SKP2 E3 ligase impairs cancer stem cell self-renewal and tumor growth.